Growth Metrics

Odyssey Health (ODYY) Long-Term Deferred Tax (2014 - 2025)

Odyssey Health's quarterly Long-Term Deferred Tax came in at $12.5 million in Q3 2025, up 2.23% year-on-year from $12.2 million in Q3 2024, and up 2.23% quarter-over-quarter from $12.2 million in Q3 2024.

Odyssey Health has reported Long-Term Deferred Tax for 8 years, with the latest figure at $12.5 million in Q3 2025.

  • For the quarter ending Q3 2025, Long-Term Deferred Tax rose 2.23% year-over-year to $12.5 million; the trailing twelve-month figure through Jul 2025 stood at $12.5 million (up 2.23% YoY), and the FY2025 full-year result was $12.5 million, up 2.23% from the prior year.
  • Long-Term Deferred Tax for Q3 2025 stood at $12.5 million, up from $12.2 million in the prior quarter.
  • The five-year high for Long-Term Deferred Tax was $12.5 million in Q3 2025, with the low at $12.2 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Odyssey Health - - -

Historic Data

Download Data 🔒
DateValue
Jul 31, 2025 12.45 Mn
Jul 31, 2024 12.18 Mn
Apr 30, 2019 349,884.00
Jan 31, 2019 336,492.00
Oct 31, 2018 324,453.00
Apr 30, 2018 275,244.00
Jan 31, 2018 249,496.00
Oct 31, 2017 208,968.00
Jul 31, 2017 275,244.00
Apr 30, 2017 194,240.00
Jan 31, 2017 184,391.00
Oct 31, 2016 155,326.00
Jul 31, 2016 107,030.00
Apr 30, 2016 133,027.00
Jan 31, 2016 130,162.00
Oct 31, 2015 115,778.00
Jul 31, 2015 107,030.00
Jan 31, 2015 84,197.00
Oct 31, 2014 66,004.00
Jul 31, 2014 50,786.00